CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the second quarter ended June 30, 2025, and recent business highlights. https://mma.prnewswire.com/media/1096384/CytoSorbents_Working_To_Save_Lives_Logo.jpg Second Quarter 2025 Financial Results — Revenue was $9.6 million, an increase of 9%, or […]